Kinase suppressor of Ras determines survival of intestinal epithelial cells exposed to tumor necrosis factor

Cancer Research

Volumn 61, Issue 24, 2001, Pages 8668-8675

  Yan, Fang ^a   John, Sutha K ^a   Polk, D Brent ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; RAF PROTEIN; RAS PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLON CARCINOGENESIS; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; CELL SURVIVAL; COLON; DNA-BINDING PROTEINS; ENZYME ACTIVATION; I-KAPPA B PROTEINS; INTESTINAL MUCOSA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035893385     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease
2. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
3. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn’s disease
4. Predominant pathogenic role of tumor necrosis factor in experimental colitis
5. Tumor necrosis factor receptor-mediated signaling pathways
6. Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line
7. Purification and partial amino acid seqence analysis of two distinct tumor necrosis factor receptors from HL60 cells
8. Death receptors: Signaling and modulation
9. Apoptosis control by death and decoy receptors
10. Apoptosis by death factor
11. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
12. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
13. Transducers of life and death: TNF receptor superfamily and associated proteins
14. The tumor necrosis factor signaling complex: Choosing a path toward cell death or cell proliferation
15. An essential role for NF-κB in preventing TNF-αinduced cell death
16. NF-κB to the rescue: RELs, apoptosis and cellular transformation
17. Suppression of TNF-α-induced apoptosis by NF-κB
18. Inhibition of TNF-induced apoptosis by NF-κB
19. NF-κB activation is required for human endothelial survival during exposure to tumor necrosis factor-α but not interleukin-1 β or lipopolysaccharide
20. L and Mcl-l and promotes survival of human pancreatic cancer cells
21. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway
22. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
23. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways
24. Regulation of neuronal survival by the serine-threonine protein kinase Akt
25. Signal transduction by the JNK group of MAP kinases
26. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
27. Opposing effects of ERK and JNK-p38 Map kinases on apoptosis
28. Conversion of TNFα from antiproliferative to prolifirative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase
29. Kinase suppressor of Ras is necessary for tumor necrosis factor a activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells
30. Epidermal and hepatocyte growth factors stimulate chemotaxis in an intestinal epithelial cell line
31. Kinase supressor of Ras is ceramide-activated protein kinase
32. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
33. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
34. Aminosalicylic acid inhibits IκB kinase α phosphorylation of IκBα in mouse intestinal epithelial cells
35. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor κB activation in mouse colonocytes
36. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
37. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
38. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
39. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
40. NF-κB: A lesson in family values
41. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. Elegans
42. Elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction
43. KSR. A novel protein kinase required for RAS signal transduction
44. The beginning of the end: IκB kinase (IKK) and NF-κB activation
45. Multiple signals converging on NF-κB
46. 269 of c-RaM-1
47. Activation of NF-κB by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade
48. Insulin activates nuclear factor κB in mammalian cells through a Raf-1-mediated pathway
49. Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation
50. The inhibitor of apoptosis, cIAP2. Functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7
51. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
52. Sphingomyelinase activates proteolytic IkB-α degradation in a cell-free system
53. BAD enables ceramide to signal apoptosis via Ras and Raf-1
54. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
55. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis
56. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts
57. Identification of constitutive and Ras-inducible phosphorylation sites of KSR: Implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression
58. Phosphorylation of the kinase suppressor of Ras by associated kinases
59. The protein kinase KSR interacts with 14-3-3 protein and Raf
60. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-α therapy in rheumatoid arthritis
61. Small bowel enteropathy: Role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-γ, TNF) in the induction of epithelial cell death and renewal
62. Apoptosis of crypt epithelial cells in ulcerative colitis
63. Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor α and not by the FasL-Fas interaction: Effect of pentoxifylline on the development of mucosal atrophy
64. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis
65. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB